Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine
- 12 July 2010
- Vol. 28 (31) , 5057-5067
- https://doi.org/10.1016/j.vaccine.2010.05.006
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Evaluation of a Whole-Blood Cytokine Release Assay for Use in Measuring Endotoxin Activity of Group B Neisseria meningitidis Vaccines Made from Lipid A Acylation MutantsClinical and Vaccine Immunology, 2010
- Characterization of an Antibody Depletion Assay for Analysis of Bactericidal Antibody SpecificityClinical and Vaccine Immunology, 2009
- Quadrivalent Meningococcal Vaccination of Adults: Phase III Comparison of an Investigational Conjugate Vaccine, MenACWY-CRM, with the Licensed Vaccine, MenactraClinical and Vaccine Immunology, 2009
- Differential Activation of Human and Mouse Toll-Like Receptor 4 by the Adjuvant Candidate LpxL1 ofNeisseria meningitidisInfection and Immunity, 2008
- Additive and Synergistic Bactericidal Activity of Antibodies Directed against Minor Outer Membrane Proteins of Neisseria meningitidisInfection and Immunity, 2007
- Affinity-Purified Human Immunoglobulin G That Binds a Lacto-N-Neotetraose-Dependent Lipooligosaccharide Structure Is Bactericidal for Serogroup BNeisseria meningitidisInfection and Immunity, 2007
- Phase 1 first-in-human studies of the reactogenicity and immunogenicity of a recombinant meningococcal NspA vaccine in healthy adultsVaccine, 2007
- A universal vaccine for serogroup B meningococcusProceedings of the National Academy of Sciences, 2006
- Meningococcal VaccinesDrugs, 1998
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970